QureTech Bio partner in Swedish Research Council-funded project
QureTech Bio partner in Swedish Research Council-funded project [...]
Research from QureTech Bio co-founders published in PNAS
Research from QureTech Bio co-founders published in PNAS October [...]
QureTech Bio co-founder Fredrik Almqvist awarded the 2025 Bo and Barbro Hammarström prize
QureTech Bio co-founder Fredrik Almqvist awarded the 2025 Bo and [...]
Professor Fredrik Almqvist to Present at Bioscience Gothenburg 2025
Professor Fredrik Almqvist to present at Bioscience Gothenburg 2025 [...]
QureTech Bio granted European patent for new class of antibacterials
QureTech Bio granted European patent for new class of [...]
QureTech Bio welcomes Dr. Mikael Sellin as Member of the Board
QureTech Bio welcomes Dr. Mikael Sellin as Member of [...]
QureTech Bio announces prestigious investment from Kempestiftelserna
QureTech Bio announces prestigious investment from Kempestiftelserna September [...]
QureTech Bio announces the appointment of Markus Thor as new CEO
QureTech Bio announces the appointment of Markus Thor as [...]
Scientific publication highlights the potential of GmPcides for treating S. pyogenes infections
Scientific publication highlights the potential of GmPcides for treating S. [...]
QureTech Bio appoints new Chairman of the Board and new Board Member
QureTech Bio appoints new Chairman of the Board and new [...]